Dr. Barzin Gavtash earned his BSc, MSc, and Ph.D. in mechanical engineering – thermofluids. His Ph.D. research was in collaboration with Chiesi Farmaceutici SpA and Loughborough University, involving computational fluid dynamics (CFD) simulation to predict the multi-phase propellant flow evolution and therapeutic droplet generation in a pressurized metered-dose inhaler (pMDI). After finishing his Ph.D. in 2016, he took on a post-doctoral position in collaboration with 3M UK PLC - Drug Delivery Systems Division, Loughborough University, and Innovate UK on design and development of next-gen nose-to-brain drug delivery devices, establishing several predictive engineering pipelines. He then joined 3M Drug Delivery Systems in 2018 (launched as Kindeva Drug Delivery in May 2020) as a specialist product development engineer, working as a member of the R&D team in Kindeva’s Inhalation Center of Excellence, Loughborough, UK. His field of expertise includes applications of predictive engineering and digital twinning in design, development, and performance optimization of next-gen drug delivery devices.